Package leaflet: Information for the user. Zirtek 1 mg/ml oral solution. Cetirizine dihydrochloride

Similar documents
PACKAGE LEAFLET For medicinal products available on prescription

Package leaflet: Information for the user. Zirtek Allergy 1 mg/ml oral solution. Cetirizine dihydrochloride

Package leaflet: Information for the user Zirtek Allergy Relief 10 mg film-coated tablets Cetirizine dihydrochloride

Package leaflet: Information for the user Zirtek Allergy Relief for Children 1 mg/ml Oral Solution Cetirizine dihydrochloride

Package Leaflet: Information for the user. Anti-Hist Allergy 10mg Film-Coated Tablets. Cetirizine dihydrochloride

PACKAGE LEAFLET For medicinal products available on prescription

Package leaflet: Information for the user. Cetiristad 10 mg film-coated tablets Cetirizine dihydrochloride

Package leaflet: Information for the user Zirtek Allergy Relief 10 mg Film Coated Tablets Cetirizine dihydrochloride

Package leaflet: Information for the patient. Cetirizin Sandoz 10 mg film-coated tablets. cetirizine dihydrochloride

Package leaflet: Information for the user. Cetirelief Allergy 10mg film-coated tablets. Cetirizine dihydrochloride

Package leaflet: Information for the patient

Package leaflet: Information for the user. Zynor Allergy 10 mg Film-coated Tablets Cetirizine dihydrochloride

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Package leaflet: Information for the patient

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the patient. Levocetirizine Krka 5 mg film-coated tablets Levocetirizine dihydrochloride

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

XYZAL 5 MG FILM-COATED TABLET

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

Cetirizine Proposed Core Safety Profile

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

2. What you need to know before you take DDAVP/Desmopressin Tablets

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Benylin Phlegm Cough Menthol 100mg/5ml Oral Solution Guaifenesin

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

Package leaflet: information for the user

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the patient. Hexvix 85 mg, powder and solvent for intravesical solution Hexaminolevulinate

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package Leaflet: Information for the user Kemadrin 5 mg Tablets Procyclidine hydrochloride

1. What Octostim Nasal Spray is and what it is used for

Package Leaflet: Information for the user. TARGAXAN 550 mg film-coated tablets rifaximin

ANDROGEL 50 mg, gel in sachet Testosterone

Package leaflet: Information for the patient. Valotix 500 mg Film-Coated Tablets Valaciclovir

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

Maxilief Effervescent Tablets

1. What Miacalcic is and what it is used for

Benylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

Package leaflet: Information for the patient LOCABIOTAL Pressurised 125 micrograms Nasal/Oromucosal spray solution Fusafungine

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the patient

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient. Avodart 0.5 mg soft capsules dutasteride

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

1 What Engerix B is and what it is used for

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

1. What Betahistine dihydrochloride tablets is and what it is used for

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

PATIENT INFORMATION LEAFLET. Active substances: Each 5 ml syrup (1 spoon) contains 2.5 mg desloratadine.

2. What you need to know before you use TESTOGEL

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

Package leaflet: Information for the user Arlevert 20 mg/40 mg tablets cinnarizine/dimenhydrinate

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package Leaflet: Information for the User. BENETOR 10 mg, 20 mg, 40 mg Film-Coated Tablets olmesartan medoxomil

Package leaflet: Information for the user. PRED MILD STERILE OPHTHALMIC SUSPENSION 0.12% w/v Eye Drops, Suspension Prednisolone Acetate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Finasteride 5mg Film-coated Tablets. (Finasteride) This medicine is for use in men only

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Cetirizine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)

Package leaflet: Information for the patient. Vimpat 10 mg/ml solution for infusion lacosamide

Package Leaflet: Information for the Patient. FOSRENOL 750 mg oral powder. FOSRENOL 1000 mg oral powder. lanthanum

Levocetirizine dihydrochloride

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Package leaflet: information for the user. Valaciclovir Bluefish 500 mg Film-Coated Tablets Valaciclovir

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the patient. Paracetamol 10 mg/ml solution for infusion. Paracetamol

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Package leaflet: Information for the user. Chirocaine mg/ml or 1.25 mg/ml solution for infusion For epidural use only.

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Flavamed Forte 30 mg/5 ml, oral solution

Package leaflet: Information for the patient

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the patient. Sycrest 5 mg sublingual tablets Sycrest 10 mg sublingual tablets asenapine

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. DRYNOL 20 MG TABLETS bilastine

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Package leaflet: Information for the patient. [To be completed nationally] 10 mg film-coated tablets Ebastine

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

Transcription:

Package leaflet: Information for the user Zirtek 1 mg/ml oral solution Cetirizine dihydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. - You must talk to a doctor if you do not feel better or if you feel worse after 3 days. What is in this leaflet: 1. What Zirtek is and what it is used for 2. What you need to know before you take Zirtek 3. How to take Zirtek 4. Possible side effects 5. How to store Zirtek 6. Contents of the pack and other information 1. What Zirtek is and what it is used for Cetirizine dihydrochloride is the active ingredient of Zirtek. Zirtek is an antiallergic medication. In adults and children aged 2 years and above, Zirtek 1 mg/ml oral solution is indicated - for the relief of nasal and ocular symptoms of seasonal and perennial allergic rhinitis. - for the relief of urticaria. 2. What you need to know before you take Zirtek Do not take Zirtek - if you have a severe kidney disease (severe renal failure with creatinine clearance below 10 ml/min); - if you are allergic to cetirizine dihydrochloride, to any of the other ingredients (listed in section 6), to hydroxyzine or to any piperazine derivatives (closely related active ingredients of other medicines). Warnings and precautions If you are a patient with renal insufficiency, please ask your doctor for advice; if necessary, you will take a lower dose. The new dose will be determined by your doctor. If you have problems passing urine (like spinal cord problems or prostate or bladder problems), please ask your doctor for advice. If you are an epileptic patient or a patient at risk of convulsions, you should ask your doctor for advice. No clinically significant interactions have been observed between alcohol (at the blood level of 0.5 per mille (g/l) corresponding to one glass of wine) and cetirizine used at the recommended doses. However, there are no data available on the safety when higher doses of cetirizine and alcohol are 2

taken together. Therefore, as it is the case with all antihistamines, it is recommended to avoid taking Zirtek with alcohol. If you are scheduled for allergy testing, ask your doctor if you should stop taking Zirtek for several days before testing. This medicine may affect your allergy test results. Other medicines and Zirtek Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Zirtek with food and drink Food does not affect absorption of Zirtek. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Zirtek should be avoided in pregnant women. Accidental use of the drug by a pregnant woman should not produce any harmful effects on the foetus. Nevertheless, the medicine should only be administered if necessary and after medical advice. Cetirizine passes into breast milk. Therefore, you should not take Zirtek during breast-feeding unless you have contacted a doctor. Driving and using machines Clinical studies have produced no evidence of impaired attention, alertness and driving capabilities after taking Zirtek at the recommended dose. You should closely observe your response to the drug after you have taken Zirtek if you are intending to drive, engage in potentially hazardous activities or operate machinery. You should not exceed the recommended dose. Zirtek oral solution contains sorbitol; if you have been told by your doctor that you have an intolerance to some sugars, please contact your doctor before taking this medicinal product. Zirtek oral solution contains methylparahydroxybenzoate (E 218), propylparahydroxybenzoate (E 216) that may cause allergic reactions (possibly delayed). 3. How to take Zirtek Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. The solution can be swallowed as such. Adults and adolescents above 12 years old: The recommended dose is 10 mg once daily as 10 ml oral solution (2 full measuring spoons) Use in children between 6 and 12 years old: The recommended dose is 5 mg twice daily as 5 ml (one full measuring spoon) twice daily. Use in children between 2 and 6 years old The recommended dose is 2.5 mg twice daily as 2.5 ml oral solution (a half-measuring spoon) twice daily Patients with renal impairment 3

Patients with moderate renal impairment are recommended to take 5 mg once daily. If you suffer from severe kidney disease, please contact your doctor or pharmacist who may adjust the dose accordingly. If your child suffers from kidney disease, please contact your doctor or pharmacist who may adjust the dose according to your child s needs. If you feel that the effect of Zirtek is too weak or too strong, please consult your doctor. Duration of treatment Duration of continuous treatment should not be longer than 30 days, after this period, you should also consult with your doctor. If you take more Zirtek than you should If you think you have taken an overdose of Zirtek please inform your doctor. Your doctor will then decide what measures, if any, should be taken. After an overdose, the side effects described below may occur with increased intensity. Adverse effects such as confusion, diarrhoea, dizziness, tiredness, headache, ailing, dilating of pupil, itching, restlessness, sedation, somnolence, stupor, abnormal rapid heart rate, tremors and urinary retention have been reported. If you forget to take Zirtek Do not take a double dose to make up for a forgotten dose. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects are rare or very rare, but you must stop taking the medicine and speak to your doctor straight away if you notice them: - Allergic reactions, including severe reactions and angioedema (serious allergic reaction which causes swelling of the face or throat). These reactions may start soon after you first take the medicine, or it might start later. Common side effects (may affect up to 1 in 10 patients) - Somnolence (sleepiness) - Dizziness, headache - Pharyngitis, rhinitis (in children) - Diarrhea, nausea, dry mouth - Fatigue Uncommon side effects (may affect up to 1 in 100 patients) - Agitation - Paresthesia (abnormal feelings of the skin) - Abdominal pain - Pruritus (itchy skin), rash - Asthenia (extreme fatigue), malaise Rare side effects (may affect up to 1 in 1,000 patients) - Allergic reactions, some severe (very rare) - Depression, hallucination, aggression, confusion, insomnia - Convulsions - Tachycardia (heart beating too fast) - Liver function abnormal 4

- Urticaria (hives) - Oedema (swelling) - Weight increased Very rare side effects (may affect up to 1 in 10,000 patients) - Thrombocytopenia (low levels of blood platelets) - Tics (habit spasm) - Syncope, dyskinesia (involuntary movements), dystonia (abnormal prolonged muscular contractions), tremor, dysgeusia (altered taste) - Blurred vision, accommodation disorder (difficulty focusing), oculogyration (eyes having uncontrolled circular movements) - Angioedema (serious allergic reaction which causes swelling of the face or throat), fixed drug eruption - Abnormal elimination of urine (bed wetting, pain and/or difficulty passing water) Not known frequency of side effects (frequency cannot be estimated from the available data) - Increased appetite - Suicidal ideation (recurring thoughts of or preoccupation with suicide) - Amnesia, memory impairment - Vertigo (sensation of rotation or movement) - Urinary retention (inability to completely empty the urinary bladder) Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Zirtek Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the box and bottle. The expiry date refers to the last day of that month. Do not use after 3 months of first opening the bottle. This medicine does not require any special storage conditions. 6. Contents of the pack and other information What Zirtek contains - The active substance is cetirizine. 10 ml (equals to 2 measuring spoons) contain 10 mg of cetirizine dihydrochloride. - The other ingredients are sorbitol (E 420), glycerol, propylene glycol, saccharin sodium, methylparahydroxybenzoate (E 218), propylparahydroxybenzoate (E 216), banana flavor 54.330/A (Firmenich), sodium acetate, glacial acetic acid, purified water. - 10 ml Zirtek oral solution (=2 measuring spoons) contain: 3.15 g glucose equivalents (sorbitol). What Zirtek looks like and contents of the pack Clear and colorless liquid with slightly sweet taste and a banana flavor. Pack with a bottle containing volumes of 60, 75, 100, 150, or 200 ml solution. Not all pack sizes may be marketed. 5

Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: UCB Pharma Ireland Ltd United Drug House Magna Drive Citywest Road Dublin 24 Manufacturer: UCB Pharma Limited, 208 Bath Road, Slough, Berkshire, SL1 3WE, United Kingdom This medicinal product is authorised in the Member States of the EEA under the following names: Austria: Zirtek 1 mg/ml orale Lösung Belgium: Zirtek Cyprus: Zirtek Denmark: Zirtek Estonia: Zirtek Finland: Zirtek France: Zirtek Ireland: Zirtek oral solution 1mg/ml Italy: Zirtec 1mg/ml soluzione orale Latvia: Zirtek Lithuania: Zirtek Luxembourg: Zirtek Malta: Zirtek Netherlands: Zirtek Norway: Zirtek Poland: Zirtek Portugal: Zirtek Slovenia: Zirtek1 mg/ml peroralna raztopina Spain: Zirtek solución oral Sweden: Zyrlex United Kingdom: Zirtek allergy solution This leaflet was last revised in 05/2015 6